Cell and gene therapy companies prioritize safety and efficacy in their treatments through rigorous research, preclinical studies, and clinical trials conducted according to regulatory guidelines and standards. They invest in advanced manufacturing processes, quality control measures, and patient monitoring protocols to ensure the safety, purity, and potency of therapeutic products. By leveraging scientific expertise, data-driven decision-making, and collaboration with regulatory authorities and healthcare stakeholders, these companies strive to bring safe and effective therapies to market, addressing critical unmet needs and improving patient care.